Skip to main content
. 2015 Jul 7;2015(7):CD010555. doi: 10.1002/14651858.CD010555.pub2
Outcomes relevant to your review
Copy and paste from ‘Types of outcome measures’
  Reported in paper (circle)
Overall mortality Yes/No
Overall 28‐day mortality (30‐day mortality included) Yes/No
   
Number of new occurrences of blood transfusion (e.g. avoidance of transfusion)  Yes/No
Number of bleeding events Yes/No
Quantity of blood products transfused Yes/No
Complications probably related to the intervention (e.g. thrombotic episodes (pulmonary embolism, myocardial infarction, disseminated intravascular coagulation), major immunological and allergic reactions (TRALI), cardiopulmonary overload (TACO), infection and sepsis (e.g. transmission of viral infection)) Yes/No
Complications during inpatient stay not specific to the trial intervention (e.g. pneumonia, congestive cardiac failure, respiratory failure, renal failure) Yes/No
  Yes/No
  Yes/No
Number of days in hospital. Yes/No
Mean length of stay in intensive care unit (ICU). Yes/No